Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02427435 | NEXGARD | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 11.3 MG | Marketed |
| 02427443 | NEXGARD | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 28.3 MG | Marketed |
| 02427451 | NEXGARD | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 68 MG | Marketed |
| 02473364 | NEXGARD SPECTRA | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 9.4 MG; MILBEMYCIN OXIME 1.9 MG | Marketed |
| 02473372 | NEXGARD SPECTRA | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 18.8 MG; MILBEMYCIN OXIME 3.8 MG | Marketed |
| 02473380 | NEXGARD SPECTRA | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 37.5 MG; MILBEMYCIN OXIME 7.5 MG | Marketed |
| 02473399 | NEXGARD SPECTRA | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 75 MG; MILBEMYCIN OXIME 15 MG | Marketed |
| 02473402 | NEXGARD SPECTRA | BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC. | Tablet (Chewable) | AFOXOLANER 150 MG; MILBEMYCIN OXIME 30 MG | Marketed |